News Sentiment

ORY sentiment intelligence

Oryzon Genomics S.A. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 47 Balanced news tone 9 relevant articles
Exchange MCE Spain
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.90 Week of 17 Jul 2026
Weighted tone 47/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 9

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+0.9% over one week, -7.5% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Oryzon Genomics S A : announces U.S. patent grant for vafidemstat in borderline personality disorder (BPD)

Market Reaction

Balanced read

52/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction 0.9% Price digesting
Trend fit Trend inactive -7.5% over four weeks
Fair value 22.3% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 5
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 9
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
marketscreener.com 2
Investing.com 2
TipRanks 1
Investing.com Canada 1
Investing.com India 1
simplywall.st 1
Market source 1

Event Lens

What the news is about

Classified themes
Market update 6
Earnings 2
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-9 of 9